- Home
- CUE vs HYPR Comparison
CUE vs HYPR Comparison
Compare CUE & HYPR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CUE
- HYPR
- Stock Information
- Founded
- CUE 2014
- HYPR 2014
- Country
- CUE United States
- HYPR United States
- Employees
- CUE N/A
- HYPR N/A
- Industry
- CUE Biotechnology: Pharmaceutical Preparations
- HYPR Medical Specialities
- Sector
- CUE Health Care
- HYPR Health Care
- Exchange
- CUE Nasdaq
- HYPR Nasdaq
- Market Cap
- CUE 48.0M
- HYPR 55.9M
- IPO Year
- CUE 2018
- HYPR N/A
- Fundamental
- Price
- CUE $0.74
- HYPR $0.77
- Analyst Decision
- CUE Strong Buy
- HYPR Strong Buy
- Analyst Count
- CUE 3
- HYPR 3
- Target Price
- CUE $3.00
- HYPR $1.06
- AVG Volume (30 Days)
- CUE 323.3K
- HYPR 309.5K
- Earning Date
- CUE 08-13-2025
- HYPR 08-07-2025
- Dividend Yield
- CUE N/A
- HYPR N/A
- EPS Growth
- CUE N/A
- HYPR N/A
- EPS
- CUE N/A
- HYPR N/A
- Revenue
- CUE $7,991,000.00
- HYPR $11,732,000.00
- Revenue This Year
- CUE N/A
- HYPR $12.31
- Revenue Next Year
- CUE $23.84
- HYPR $29.29
- P/E Ratio
- CUE N/A
- HYPR N/A
- Revenue Growth
- CUE 13.83
- HYPR 0.34
- 52 Week Low
- CUE $0.45
- HYPR $0.53
- 52 Week High
- CUE $1.99
- HYPR $1.90
- Technical
- Relative Strength Index (RSI)
- CUE 51.10
- HYPR 56.00
- Support Level
- CUE $0.65
- HYPR $0.76
- Resistance Level
- CUE $0.83
- HYPR $0.82
- Average True Range (ATR)
- CUE 0.07
- HYPR 0.05
- MACD
- CUE 0.01
- HYPR 0.01
- Stochastic Oscillator
- CUE 30.43
- HYPR 72.94
About CUE Cue Biopharma Inc.
Cue Biopharma Inc is a clinical-stage biopharmaceutical company. It is developing a novel and proprietary class of biologics drugs for the selective modulation of the human immune system to treat a broad range of cancers and autoimmune disorders. Its objective is to provide patients suffering from cancer and autoimmune diseases with dramatically improved therapeutic outcomes through the platform of biologic drug product candidates. The other products under pipeline are CUE-101 as a Monotherapy, CUE-101 + Pembrolizumab, CUE-102, CUE-103, and others.
About HYPR Hyperfine Inc.
Hyperfine Inc is a medical device company that created Swoop. The Swoop Portable MR Imaging System produces high-quality images at a lower magnetic field strength than conventional MRI scanners. The company derives its revenue from sale of sales of MRI devices and service sales which consist of sales from subscriptions of bundled devices, maintenance, and software.